Elevation Oncology (ELEV) CEO Ferra acquired 12,563 shares
Insider transactions reported
Joseph J Ferra Jr (Chief Executive Officer at Elevation Oncology Inc., ELEV) reported that they acquired 12,563 shares, and gave up 4,629 shares at $0.64 to cover taxes or an exercise price on Dec 16, 2024. After these transactions the filing shows 109,482 shares held directly.
- Reporting person
- Ferra Joseph J Jr
- Role
- CHIEF EXECUTIVE OFFICER
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Dec 16, 2024 | Exercise or conversion of a derivative (M) | Common Stock1 | +12,563 | - | - | 114,111 direct |
| Dec 16, 2024 | Shares withheld for taxes or exercise price (F) | Common Stock | -4,629 | $0.64 | $2,963 | 109,482 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Dec 16, 2024 | Exercise or conversion of a derivative (M) | Restricted Stock UnitOn 12,563 Common Stock1, 2, 3 | -12,563 | - | - | 25,122 direct |
Holdings before and after
- Common Stock: 101,548 to 109,482 direct
- Restricted Stock Unit: 37,685 to 25,122 direct
Footnotes from the filing
- 1. Each restricted stock unit ( RSU ) represents a contingent right to receive one share of the Issuer's common stock.
- 2. 25% of the RSUs vested on June 16, 2022, and the remainder will vest as to 1/16 of the total RSUs quarterly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
- 3. The RSUs do not expire; they either vest or are canceled prior to the vesting date.
Transaction codes in this filing
- Exercise or conversion of a derivative:
- Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
- Shares withheld for taxes or exercise price:
- Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
FAQ
What did Ferra report in this ELEV Form 4?
Joseph J Ferra Jr (Chief Executive Officer at Elevation Oncology Inc., ELEV) reported that they acquired 12,563 shares, and gave up 4,629 shares at $0.64 to cover taxes or an exercise price on Dec 16, 2024. After these transactions the filing shows 109,482 shares held directly.
How many ELEV shares does Ferra hold after this filing?
The filing shows 109,482 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code M mean on an SEC Form 4?
Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
Historical context for ELEV
Earlier insider filings at ELEV
- Nov 19, 2024CHIEF FINANCIAL OFFICER Furlong Tammy converted options into 300 shares and covered exercise/tax liability with 98 shares, increasing direct ownership by 17% to 1,410 units (SEC Form 4)
- Sep 18, 2024CHIEF EXECUTIVE OFFICER Ferra Joseph J Jr converted options into 12,562 shares and covered exercise/tax liability with 4,628 shares, increasing direct ownership by 8% to 101,548 units (SEC Form 4)
- Aug 19, 2024CHIEF FINANCIAL OFFICER Furlong Tammy converted options into 300 shares and covered exercise/tax liability with 89 shares, increasing direct ownership by 21% to 1,208 units (SEC Form 4)
- Jun 18, 2024CHIEF EXECUTIVE OFFICER Ferra Joseph J Jr converted options into 12,562 shares and covered exercise/tax liability with 4,628 shares, increasing direct ownership by 9% to 93,614 units (SEC Form 4)
- Jun 17, 2024SEC Form 4 filed by Director Sandler Alan B.
Keep researching ELEV
- ELEV insider tradesEvery buy and sale reported by Elevation Oncology Inc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 2021
Follow ELEV and get a push notification the moment its next story breaks.